PNC Financial Services Group’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
KCM
PNC Financial Services Group's LEGN Position: Q2 2026 in Review
PNC Financial Services Group increased its Legend Biotech (LEGN) stake by 13% in Q2 2026, buying an estimated $70.6K and bringing the position to 23,336 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.
PNC Financial Services Group first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.
- PNC Financial Services Group held 23,336 shares of Legend Biotech worth $674K as of Q2 2026.
- PNC Financial Services Group bought 2,617 Legend Biotech shares in Q2 2026, an estimated $70.6K.
- Legend Biotech made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1603 holding.
- PNC Financial Services Group first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
- 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.